Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study-Reference-Cited by-同舟云学术

Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study

Published:2017-12-21 Issue:27 Volume:1 Page:2790-2798
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Thorsteinsdottir Sigrun¹²,Lund Sigrun H.²,Lindqvist Ebba K.³,Thordardottir Marianna²,Sigurdsson Gunnar⁴,Costello Rene⁵,Burton Debra⁵,Steingrimsdottir Hlif¹,Gudnason Vilmundur²⁴,Eiriksdottir Gudny⁴,Siggeirsdottir Kristin⁴,Harris Tamara B.⁶,Landgren Ola⁷,Kristinsson Sigurdur Y.¹²

Affiliation:

1. Department of Internal Medicine, Landspitali–The National University Hospital of Iceland, Reykjavik, Iceland;

2. Faculty of Medicine, University of Iceland, Reykjavik, Iceland;

3. Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden;

4. Icelandic Heart Association, Kopavogur, Iceland;

5. Center for Cancer Research, National Cancer Institute, and

6. National Institute on Aging, National Institutes of Health, Bethesda, MD; and

7. Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Abstract

Key PointsIndividuals with MGUS did not have a decreased BMD compared with others in a screened population. Individuals with MGUS had an increased bone volume at the hip and lumbar spine compared with others.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/27/2790/879240/advances010454.pdf

Reference37 articles.

1. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study;Dispenzieri;Lancet,2010

2. Prevalence of monoclonal gammopathy of undetermined significance;Kyle;N Engl J Med,2006

3. Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management;Kristinsson;Expert Rev Mol Diagn,2011

4. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study;Kristinsson;Blood,2010

5. Fracture risk in patients with monoclonal gammopathy of undetermined significance;Gregersen;Br J Haematol,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance;Annals of Internal Medicine;2024-06-18

2. Discrepant serum creatinine concentrations caused by paraprotein interference preceding diagnosis of monoclonal gammopathy of undetermined significance;BMJ Case Reports;2024-04

3. Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study;Haematologica;2023-07-13

4. Investigation and management of the monoclonal gammopathy of undetermined significance;British Journal of Haematology;2023-05-18

5. Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample;Thrombosis Research;2023-05